Jan 27, 2021 | False Claims Act
False Claims Act (“FCA”) matters have a notoriously long lifespan. United States v. Mortgage Investors Corporation, 2021 WL 137739 (11th Cir. 2021), has had an exceptionally long life. Originally filed on March 3, 2006, after nearly fifteen years, this case has been...
Jan 25, 2021 | False Claims Act
Late last year, the Supreme Court declined to review the Fifth Circuit Court of Appeals’ decision in U.S. ex rel. Integra Med Analytics, LLC v. Baylor, Scott & White Health, et al., a decision affirming the dismissal of a False Claims Act complaint that relied...
Jan 19, 2021 | False Claims Act
In a press release on January 14, the U.S. Department of Justice released its False Claims Act Statistics for Fiscal Year 2020. In total, the federal government recovered over $2.2 billion in settlements and judgments from False Claims Act cases brought against...
Jan 15, 2021 | False Claims Act
The DOJ announced it recently settled with durable medical equipment supplier Apria Healthcare to resolve allegations of fraudulent billing practices related to the rental of non-invasive ventilators (“NIVs”). The case was originally brought in the Southern District...
Jan 15, 2021 | COVID-19 Related Law, False Claims Act, Fraud Investigations
In April 2020, CG attorneys wrote about the increased risk of government scrutiny for recipients of the CARES Act Paycheck Protection Program (PPP), which initially provided over $349 billion in forgivable PPP loans to small businesses. As Congress authorized hundreds...
Dec 22, 2020 | False Claims Act
In July 2020, CG attorneys discussed two settlements by Novartis Pharmaceuticals Corporation for $729 million involving allegations that Novartis paid kickbacks to doctors and patients. One settlement involved Novartis agreeing to pay $51.25 million to resolve...
